Comorbidity in older adults: Nosology of impairment, diseases, and conditions

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 62, Issue 3, 2007, Pages 296-300

  Karlamangla, Arun S ^a,f   Tinetti, Mary ^b   Guralnik, Jack ^c   Studenski, Stephanie ^d   Wetle, Terrie ^e   Reuben, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e BROWN UNIVERSITY   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANAMNESIS; CARDIOVASCULAR FUNCTION; COMORBIDITY; DIGESTIVE FUNCTION; DISEASE CLASSIFICATION; FUNCTIONAL ASSESSMENT; HEALTH STATUS; HUMAN; IMMUNE FUNCTION TEST; INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH; MENTAL FUNCTION; METABOLISM; PATIENT CODING; PERFORMANCE; PRIORITY JOURNAL; RESPIRATORY FUNCTION; REVIEW; SPEECH; VOICE; WORLD HEALTH ORGANIZATION; CHRONIC DISEASE; CLASSIFICATION; DIAGNOSIS; DISABLED PERSON; PHYSIOLOGY; RESEARCH; THERAPY;

CHRONIC DISEASE; DIAGNOSIS; DISABLED PERSONS; HEALTH STATUS; HUMANS; PHYSIOLOGY; RESEARCH; THERAPEUTICS;

EID: 34248519461     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/62.3.296     Document Type: Review

References (40)

1. Van den Akker M, Buntinx F, Metsemakers JFM, et al.Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol. 1998; 51:367-375.
2. Guralnik JM. Assessing the impact of comorbidity in the older population. Ann Epidemiol. 1996;6:376-380.
3. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162:2269-2276.
4. Harris TB. Epidemiology and aging. In: Cassel CK, Leipzig RM, Cohen HJ, et al. Geriatric Medicine: An Evidence-Based Approach, Fourth Edition. New York: Springer Verlag; 2003.
5. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004;59A:255-263.
6. Yancik R, Ganz PA, Varricchio CG, Conley B. Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base. J Clin Oncol. 2001;19:1147-1151.
7. Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis. 1970;23:455-468.
8. Khaw KT, Wareham N, Luben R, et al.Glycated hemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ. 2001; 322:15-18.
9. Seeman TE, Singer BH, Rowe JW, et al.Price of adaptation-Allostatic load and its health consequences. Arch Intern Med. 1997;157:2259-2268.
10. Karlamangla AS, Singer BH, McEwen BS, Rowe JW, Seeman TE. Allostatic load as a predictor of functional decline: MacArthur Studies of Successful Aging. J Clin Epidemiol. 2002;55:696-710.
11. World Health Organization. Toward a Common Language of Functioning, Disability, and Health. The International Classification of Functioning, Disability, and Health (ICF). Geneva, Switzerland: World Health Organization; 2002.
12. Guralnik JM, Ferrucci L. Assessing the building blocks of function. Am J Prev Med. 2003;25(3Sii):112-121.
13. Penninx BW, Guralnik JM, Bandeen-Roche K, et al.The protective effect of emotional vitality on adverse health outcomes in disabled older women. J Am Geriatr Soc. 2000;48:1359-1366.
14. Federal Interagency Forum on Aging Related Statistics. Older Americans Update 2006: Key Indicators of Well-Being. Washington, DC: US Government Printing Office. May 2006.
15. Huang BY, Comoni-Huntley J, Hays JC, Huntley RR, Galanos AN, Blazer DG. Impact of depressive symptoms on hospitalization risk in community-dwelling older persons. J Am Geriatr Soc. 2000;48:1279-1284.
16. Chodosh J, Reuben D, Albert M, et al.Predicting cognitive impairment in high-functioning community-dwelling older persons: MacArthur Studies of Successful Aging. J Am Geriatr Soc. 2002;50:1051-1060.
17. Miller EA, Weissert WG. Predicting elderly people's risk for nursing home placement, hospitalization, functional impairment, and mortality: a synthesis. Med Care Res Rev. 2000;57:259-297.
18. Reuben DB, Mui S, Damesyn M, Moore AA, Greendale GA. The prognostic value of sensory impairment in older persons. J Am Geriatr Soc. 1999;47:930-935.
19. Appollonio I, Carabellese C, Magni E, et al.Sensory impairments and mortality in an elderly community: a six year follow up study. J Am Geriatr Soc. 1993;41:401-407.
20. Wallace JI, Schwartz RS, LaCroix AZ, Uhlmann RF, Pearlman RA. Involuntary weight loss in older outpatients: incidence and clinical significance. J Am Geriatr Soc. 1995;43:329-337.
21. McEwen BS, Stellar E. Stress and the individual: mechanisms leading to disease. Arch Intern Med. 1993;153:2093-2101.
22. Lipsitz LA, Goldberger AL. Loss of complexity and aging. Potential applications of fractals and chaos theory to senescence. JAMA. 1992;267:1806-1809.
23. Hansen AL, Johnsen BH, Sollers JJ 3rd, Stevnik K, Thayer JF. Heart rate variability and its relation to prefrontal cognitive function: the effects of training and detraining. Eur J Appl Physiol. 2004;93:263-272.
24. Lauer MS, Okin PM, Larson MG, Evans JC, Levy D. Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study. Circulation. 1996;93:1520-1526.
25. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847.
26. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
27. Grundy SM, Cleeman JI, Merz CMB, et al. for the Coordinating Committee of the National Cholesterol Education Program.Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation. 2004;110: 227-239.
28. Burg MM, Benedetto MC, Soufer R. Depressive symptoms and mortality two years after coronary artery bypass graft surgery (CABG) in men. Psychosom Med. 2003;65:508-510.
29. Penninx BW, Beekman AT, Honig A, et al.Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry. 2001;58:221-227.
30. Fried LP, Bandeen-Roche K, Kasper JD, et al.Association of comorbidity with disability in older women: the Women's Health and Aging Study. J Clin Epidemiol. 1999;52:27-37.
31. Singh BM, Mehta JL. Interactions between the renin-angiotensin system and dyslipidemia: relevance in the therapy of hypertension and coronary heart disease. Arch Intern Med. 2003;163:1296-1304.
32. Genest JJ, Cohn JS. Clustering of cardiovascular risk factors: targeting high-risk individuals. Am J Cardiol. 1995;76:8A-20A.
33. Jousilahti P, Tuomilehto J, Vartiainen E, et al.Importance of risk factor clustering in coronary heart disease mortality and incidence in eastern Finland. J Cardiovasc Risk. 1995;2:63-70.
34. Schulze MB, Rimm EB, Li T, Rifai N, Stampfer MJ, Hu FB. C-reactive protein and incident cardiovascular events among men with diabetes. Diabetes Care. 2004;27:889-894.
35. Fox CS, Sullivan L, D'Agostino RB Sr, Wilson PW; Framingham Heart Study. The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. Diabetes Care. 2004;27:704-708.
36. Spijkerman AM, Dekker JM, Nijpels G, et al.Impact of diabetes duration and cardiovascular risk factors on mortality in type 2 diabetes: the Hoom Study. Eur J Clin Invest. 2002;32:924-930.
37. Writing Team for the Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA. 2002;287:2563-2569.
38. Hakim AA, Curb JD, Burchfield CM, et al.Screening for coronary heart disease in elderly men based on current and past cholesterol levels. J Clin Epidemiol. 1999;52:1257-1265.
39. McDade TW, Burhop J, Donhal J. High-sensitivity enzyme immunoassay for C-reactive protein in dried blood spots. Clin Chem. 2003;50:652-654.
40. Eross J, Kreutzmann D, Jimenez M, et al.Colorimetric measurement of glycosylated protein in whole blood, red blood cells, plasma, and dried blood. Ann Clin Biochem. 1984;21:477-483.